Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: Correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1)

European Journal of Gynaecological Oncology

Volumn 24, Issue 3-4, 2003, Pages 299-304

  Zagorianakou, N ^a   Ioachim, E ^a   Mitselou, A ^a   Kitsou, E ^b   Zagorianakou, P ^a   Makrydimas, G ^a   Salmas, M ^c   Agnantis, N J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

Author keywords

Endometrial carcinoma; ER; HSP27; MIB1; P53; PCNA; PR

Indexed keywords

ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 27; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53;

ADENOMYOSIS; ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; HISTOPATHOLOGY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; NORMAL HUMAN; POSTMENOPAUSE; PREMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STATISTICAL ANALYSIS; STRESS;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037676135     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ciocca D.R., Oesterreich S., Chamnss G.C., McGuire W.L., Fuqua S.A.: "Biological and clinical implications of heat shock protein 27000 (HSP27): a review". J. Nat. Cancer Institute, 1993, 85, 1558.
2. Mahvi D.M., Carper S.W., Storm F.K.: "Over-expression of 27kDa-heat shock protein in MCF-breast cancer cells: Effects on lymphocyte killing by natural killer and gamma delta T cells". Cancer Immunol. Immunother., 1993, 37, 181.
3. Ciocca D.R., Adams D.J., Edwards D.P., Bjercke R.J., McGuire W.L.: "Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant tissues and cells". Cancer Res., 1983, 31, 1204.
4. Adams D.J., McGuire W.L.: "Quantitative enzyme-linked immunoassorbent assay for the estrogen related Mr 24,000 protein in human breast tumors: Correlation with estrogen and progesterone receptors". Cancer Res., 1985, 45, 2445.
5. Ciocca D.R., Suzann A.W. Fuqua, Sarah Lock-Lim, David O. Toft, William J. Welch, William L. McGuire: "Response of human breast cancer cells to heat shock and chemotherapeutic drugs". Cancer Res., 1992, 52, 3648.
6. Oesterreich S., Weng C.N., Qiu M., Hilsenbeck S., Osborne C.K., Suzann A. W., Fuqua A.W.: "The small heat shock protein HSP27 is correlated with growth and drug resistance in human breast cancer cell lines". Cancer Res., 1993, 53, 4443.
7. Kamishima T., Fukuda T., Yoshiya N., Suzuki T.: "Expression and intracellular localization of heat shock proteins in multidrug resistance of a cisplatin resistant human ovarian cancer cell line". Cancer Lett., 1997, 116, 205.
8. Geisler J.P., Hans E., Geisler H.E., Tammela J., Wiemann M.C., Zhou Z. et al.: "Heat shock protein 27: An independent prognostic indicator of survival in patients with epithelial ovarian carcinoma". Gynecol. Oncol., 1998, 69, 14.
9. Park C.S., Joo I.S., Song S.Y., Kim D.S., Bae D.S., Lee J.H.: "An Immunohistochemical analysis of heat shock protein 70, p53 and estrogen receptor status in carcinoma of the uterine cervix". Gynecol. Oncol., 1999, 74, 53.
10. Geisler J.P., Geisler H.E., Tammela J., Wiemann M.C., Zhou Z., Miller G.A., Crabtree W.: "Heat shock protein 27: An independent prognostic indicator of survival in patients with epithelial ovarian carcinoma". Gynecol. Oncol., 1998, 69, 14.
11. Nakapoulou K., Lazaris A.C., Baltas D., Giannopoulou I., Kavanzaw N., Tsonou A.: "Prognostic evaluation of estrogen regulated protein immunoreactivity in ductal invasive (NOS) breast cancer". Virchows Arch., 1995, 427, 33.
12. Storm F.K., Mahvi D.M., Gilchrist K.W.: "Lack of association between tumor necrosis and HSP27 expression in primary breast cancer". J. Surg. Oncol., 1996, 61, 14.
13. Seymour L., Bezwoda W.R., Meyer K.: "Tumor factors predicting for prognosis in metastatic breast cancer". Cancer, 1990, 66, 2390.
14. Tetu B., Brisson J., Landry J., Huot J.: "Prognostic significance of heat shock protein-27 in node positive breast carcinoma: An immunohistochemical study". Breast Cancer Res. Treat., 1995, 36, 93.
15. Tetu B., Lacasse B., Boucard H.L., Lagace R., Huot J., Landry J.: "Prognostic influence of HSP-27 in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study". Cancer Res., 1992, 52, 2325.
16. Kawanishi K., Shiozaki H., Doki Y., Sakita I., Inoue M., Yano M. et al.: "Prognostic significance of heat shock protein 27 and 70 in patients with squamous cell carcinoma of esophagus". Cancer, 1999, 85, 1649.
17. Harisson J.D., Jones J.A., Ellis I.O., Morris D.L.: "Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer". Br. J. Surg., 1991, 78, 334.
18. Storm F.K., Mahvi D.M., Gilchrist K.W.: "HSP-27 has no diagnostic or prognostic significance in prostate or bladder cancer". Urology, 1993, 42, 379.
19. Devaja O., King R.J., Papadopoulos A., Raju K.S.: "Heat-shock protein 27 and its role in female reproductive organs". Eur. J. Gynaecol. Oncol., 1997, 18, 16.
20. Ciocca D.R., Puy L.A., Fasoli L.C.: "Studies of estrogen receptor, progesterone receptor, and estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix". Cancer Res., 1989, 4, 4298.
21. Ciocca D.R., Stati A.O., Amprino de Castro M.M.: "Colocalization of estrogen and progesterone receptors with an estrogen regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue". Breast Cancer Res. Treat., 1990, 16, 243.
22. McGuire W.L., Dressler L.G., Sledge G.W., Ramzy I., Ciocca D.R.: "An estrogen-regulated protein in normal and malignant endometrium". J. Steroid. Biochem., 1986, 24, 155.
23. Geisler J.P., Geisler H.F., Tammela J., Miller G.A., Wiemann M.C., Zhou Z.: "A study of heat shock protein 27 in endometrial carcinoma". Gynecol. Oncol., 1999, 72, 347.
24. Raju K.S., King R.J., Kaern J., Sumner D., Abeler V.M., Mandalaya S., Trope C.: "Influence of HSP27 and steroid receptor status on provera sensitivity, DNA-ploidy and survival of females with endometrial cancer". Int. J. Gynecol. Cancer, 1995, 5, 94.
25. Wataba K., Saito T., Fukunaka K., Ashihara K., Nishimura M., Kudo R.: "Over-expression of heat shock proteins in carcinogenic endometrium". Int. J. Cancer, 2001, 91, 448.
26. FIGO stages-1988 revision. Gynecol. Oncol., 1989, 35, 125.
27. Segreti E.M., Novotny D.B., Soper J. T., Mutch D.G., Creasman W.T., McCarty K.S.: "Endometrial cancer: histologic correlates of immunohistochemical localization of progesterone and estrogen receptor". Obstet. Gynecol., 1989, 73, 780.
28. Sung C.J., Zheng Y., Quddus M.R., Kang X., Zhang Z.F., Lauchlan S.C., Zheng W.: "p53 as a significant prognostic marker in endometrial carcinoma". Int. J. Gynecol. Cancer, 2000, 10, 119.
29. Lindquist S., Craig E.A.: "The heat shock proteins". Ann. Rev. Genet., 1988, 22, 631.
30. Edwards D.P., Adams D.J., Savage N., McGuire W.L.: "Estrogen induced synthesis of specific proteins in human breast cancer cells". Biochem. Biophys. Res. Commun., 1980, 93, 804.
31. Masiakowski P., Breathnach R., Bloch J., Gannon F., Krust A., Chambon P.: "Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line". Nucleic Acids Res., 1982, 10, 7895.
32. Khalid H., Tsutsumi K., Yamashita H., Kishikawa M., Yasunaga A., Shibata S.: "Expression of the small heat shock protein (HSP) 27 in human astrocytomas correlates with histologic grades and tumour growth fractions". Cell. Mol. Neurobiol., 1995, 15, 257.
33. Fortin A., Raybaud-Diogene H., Tetu B., Deschenes R., Huot J., Landry J.: "Overexpression of the 27 KDa heat shock protein is associated with thermoresistance and chemoresistance but not with radioresistance". Int. J. Radiat. Oncol. Biol. Phys., 2000, 46, 1259.
34. Malusecka E., Zborek A., Krzyzowska-Gruca S., Krawczyk Z.: "Expression of heat shock proteins HSP70 and HSP27 in primary non-small cell lung carcinomas. An immunohistochemical study". Anticancer Res., 2001, 21, 1015.
35. Vargas-Roig L.M., Fanelli M.A., Lopez L.A., Gago E.E., Tello O., Aznar J.C., Ciocca D.R.: "Heat shock proteins and cell proliferation in human breast cancer biopsy samples". Cancer Detect. Prev., 1997, 21, 441.